Secondary analysis of a diabetes prevention trial: about 19 years after randomisation to metformin, lifestyle intervention or placebo, lung function and respiratory symptoms did not differ by group in the 1888 participants with spirometry.
Secondary analysisn = 1,888
Pistenmaa et al. Lung function after randomization to metformin, lifestyle intervention or placebo in the Diabetes Prevention Program Outcomes Study (DPPOS)